Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children (Q45363218)
scientific article published on February 1, 2012
Language:
(P31) (Q13442814)
(P50) (Q107723691)
(P304) 109-114
(P407) (Q1860)
(P433) 2
(P478) 31
(P577) Wednesday, February 1, 2012
Wednesday, February 1, 2012
(P921) (Q1810913)
(P953) http://journals.lww.com/00006454-201202000-00002
(P1433) (Q15756717)
(P1476) "Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children" (language: en)
"Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children" (language: en)
(P2093) Elissa Malkin
Nazha Abughali
Judith Falloon
Tingting Yi
Filip Dubovsky
MI-CP149 Investigators
(P2860) (Q34938343)
(Q40399153)
(Q34285502)
(Q37384009)
(Q44975332)
(Q45788311)
(Q71658249)
(Q40513717)
(Q39593656)
(Q39997643)
(Q37568127)
(Q50619591)
(Q45384017)
(Q33974507)
(Q45549996)
(Q40541369)
(Q45420926)
(Q45736044)
(Q45785698)
other details
description scientific article published on February 1, 2012

External Links